you re absolutely right that with the vaccine, it was, you know, quick, great, we should celebrate that. and, if i may say so, private sector led. no, it wasn t private sector led, there was both public and private. there s six different vaccines. the mrna, a technology of thejohnson &johnson vaccine, for example, was all early stage darpa funded, but that s not really the point. of course there was private sector investment, there was also public sector investment. in the us, the national institutes of health spend, every year, $40 billion on health innovation. many of these vaccines, the technology behind them, actually started decades ago, so it s always public and private, itruly believe, in partnership. the problem is, if you look at the vaccine, the mission, if we want to use that word, is not the vaccine, the mission is to vaccinate everybody globally and to make the vaccine accessible. on that front, we have failed miserably. and dr tedros at the world health organization, who
pretty darned well. the private sector was activated very quickly, pump primed with some state money in the united states and in countries like the uk, and with extraordinary speed and skill, the private sector came up with solutions. came up with effective vaccines. well, ok, so first of all, we were unprepared on different levels. you know, test and trace failed miserably in the beginning. in fact, in the uk, we had to outsource it to deloitte, that didn t do too well. so the kind of local productive capacity and governance capacity of many different countries wasn t actually there for that early lockdown. you re absolutely right that with the vaccine, it was, you know, quick, great, we should celebrate that. and, if i may say so, private sector led. no, it wasn t private sector led, there was both public and private. there s six different vaccines. the mrna, a technology of thejohnson &johnson vaccine, for example, was all early stage darpa funded, but that s not really the point. o
on the vaccine rollout, that the systems we have in place actually work pretty darned well. the private sector was activated very quickly, pump primed with some state money in the united states and in countries like the uk, and with extraordinary speed and skill, the private sector came up with solutions. came up with effective vaccines. well, ok, so first of all, we were unprepared on different levels. you know, test and trace failed miserably in the beginning. in fact, in the uk, we had to outsource it to deloitte, that didn t do too well. so the kind of local productive capacity and governance capacity of many different countries wasn t actually there for that early lockdown. you re absolutely right that with the vaccine, it was, you know, quick, it was great, we should celebrate that. and, if i may say so, private sector led. no, it wasn t private sector led, there was both public and private. there s six different vaccines. the mrna, a technology of thejohnson &johnson vaccine, fo
celebrate that. and, if i may say so, private sector led. no, it wasn t private sector led, there was both public and private. there s six different vaccines. the mrna, a technology of thejohnson &johnson vaccine, for example, was all early stage darpa funded, but that s not really the point. of course there was private sector investment, there was also public sector investment. in the us, the national institutes of health spend, every year, $40 billion on health innovation. many of these vaccines, the technology behind them, actually started decades ago. so it s always public and private, itruly believe, in partnership. the problem is, if you look at the vaccine, the mission if we want to use that word, is not the vaccine, the mission is to vaccinate everybody globally and to make the vaccine accessible. and dr tedros at the world health organization, who i work with quite closely, calls it vaccine apartheid , where you have 80% of the vaccines being hoarded by a very small group